Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

SOMATROGON-GHLA for Short stature: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 31 adverse event reports in the FDA FAERS database where SOMATROGON-GHLA was used for Short stature.

Most Reported Side Effects for SOMATROGON-GHLA

Side Effect Reports % Deaths Hosp.
Injection site pain 738 69.8% 0 2
Wrong technique in device usage process 43 4.1% 0 0
Injection site erythema 42 4.0% 0 0
Incorrect dose administered by device 41 3.9% 0 0
Injection site swelling 38 3.6% 0 0
Off label use 29 2.7% 0 3
Patient-device incompatibility 29 2.7% 0 0
Headache 27 2.6% 0 3
Needle issue 27 2.6% 0 0
Device mechanical issue 24 2.3% 0 0
Device delivery system issue 23 2.2% 0 0
Incorrect dose administered 22 2.1% 0 0
Drug dose omission by device 21 2.0% 0 0
Injection site mass 21 2.0% 0 0
Device leakage 19 1.8% 0 0

Other Indications for SOMATROGON-GHLA

Growth hormone deficiency (373) Dwarfism (110) Hypopituitarism (38) Blood growth hormone (5) Blood growth hormone decreased (5)

Other Drugs Used for Short stature

SOMATROPIN (3,370) LONAPEGSOMATROPIN-TCGD (41) MECASERMIN (29) LETROZOLE (7) LEUPROLIDE (6) DUPILUMAB (5)

Related Pages

SOMATROGON-GHLA Full Profile All Short stature Drugs SOMATROGON-GHLA Demographics SOMATROGON-GHLA Timeline